Clinical Trials Browser

Phase 2 × Transurethral Resection of Bladder × Dermatologic × Clear all

NCT06151847 2024-02-28

Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma

Phase 2 Unknown

Melanoma